TY - JOUR
T1 - A1c Gear
T2 - Laboratory quality HbA1c measurement at the point of care
AU - Ejilemele, Adetoun
AU - Unabia, Jamie
AU - Ju, Hyunsu
AU - Petersen, John R.
N1 - Publisher Copyright:
© 2015.
PY - 2015/5/1
Y1 - 2015/5/1
N2 - Introduction: HbA1c is an important part of assessing the diabetic control and since the use of point-of-care devices for monitoring HbA1c is increasing, it is important to determine how these devices compare to the central laboratory. Methods: One hundred and twenty patient samples were analyzed on the Bio-Rad Variant™II and one POC analyzer (Sakae A1c Gear). Three patient sample pools containing ~. 5%, ~. 7%, and ~. 10% HbA1c levels were run over 20. days. Three reagent lots and three instruments were evaluated for the A1c Gear. Results: The 120 patient samples showed strong correlation (R2>0.989) when compared to the Variant™II with means=8.06% and 7.81%, for Variant IIand A1c Gear, respectively. Changing reagent lots or instruments had no impact for the A1c Gear. The ~5%, ~7%, and ~10% pools within-run and between-run imprecision was between 0.87-1.33% and 1.03-1.32%, and 1.41-2.35% and 1.24-1.89% with total imprecision of 1.67-2.35% and 1.61-2.31% for the A1c Gear and Variant II, respectively. The A1c Gear showed a small negative bias (0.25% HbA1c) across HbA1c measurement ranges of <11.5%. This bias was, however, acceptable and not considered to be clinically significant. Conclusions: The A1c Gear meets the criteria of total CV < 3% leading us to the conclusion that the A1c Gear can give results as precise as the laboratory at the POC.
AB - Introduction: HbA1c is an important part of assessing the diabetic control and since the use of point-of-care devices for monitoring HbA1c is increasing, it is important to determine how these devices compare to the central laboratory. Methods: One hundred and twenty patient samples were analyzed on the Bio-Rad Variant™II and one POC analyzer (Sakae A1c Gear). Three patient sample pools containing ~. 5%, ~. 7%, and ~. 10% HbA1c levels were run over 20. days. Three reagent lots and three instruments were evaluated for the A1c Gear. Results: The 120 patient samples showed strong correlation (R2>0.989) when compared to the Variant™II with means=8.06% and 7.81%, for Variant IIand A1c Gear, respectively. Changing reagent lots or instruments had no impact for the A1c Gear. The ~5%, ~7%, and ~10% pools within-run and between-run imprecision was between 0.87-1.33% and 1.03-1.32%, and 1.41-2.35% and 1.24-1.89% with total imprecision of 1.67-2.35% and 1.61-2.31% for the A1c Gear and Variant II, respectively. The A1c Gear showed a small negative bias (0.25% HbA1c) across HbA1c measurement ranges of <11.5%. This bias was, however, acceptable and not considered to be clinically significant. Conclusions: The A1c Gear meets the criteria of total CV < 3% leading us to the conclusion that the A1c Gear can give results as precise as the laboratory at the POC.
KW - Diabetes
KW - HbA1c
KW - POCT
UR - http://www.scopus.com/inward/record.url?scp=84926348002&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84926348002&partnerID=8YFLogxK
U2 - 10.1016/j.cca.2015.03.011
DO - 10.1016/j.cca.2015.03.011
M3 - Article
C2 - 25801216
AN - SCOPUS:84926348002
SN - 0009-8981
VL - 445
SP - 139
EP - 142
JO - Clinica Chimica Acta
JF - Clinica Chimica Acta
ER -